FDA-Drug2023-01-11Class II
Epi-Caine, Epinephrine 0.025% Lidocaine HCL 0.75% Solution for Intraocular Injection, 1 ml, Single Dose Vial, Compounded by Pine Pharmaceuticals, 355 Riverwalk Pkwy, Tonawanda, NY 14150. NDC 69194-0948-1
Pine Pharmaceuticals, LLC
Hazard
CGMP Deviations: Raw material recalled by repackager, due to discoloration.
Sold states
Nationwide to medical facilities.
Affected count
11,453 vials
Manufactured in
355 Riverwalk Pkwy, N/A, Tonawanda, NY, United States
Products
Epi-Caine, Epinephrine 0.025% Lidocaine HCL 0.75% Solution for Intraocular Injection, 1 ml, Single Dose Vial, Compounded by Pine Pharmaceuticals, 355 Riverwalk Pkwy, Tonawanda, NY 14150. NDC 69194-0948-1
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0130-2023Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief